Company AroCell AB (publ) Nasdaq Stockholm
Equities
SE0003883990
Biotechnology & Medical Research
Business Summary
Sales per Business
SEK in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Research and Development in Cell Biology and Medicine
100.0
%
| 0 | 100.0 % | 12 | 100.0 % | +14,180.95% |
Sales per region
SEK in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | 100.0 % | 12 | 100.0 % | +14,180.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anders Hultman
CEO | Chief Executive Officer | 50 | 30/11/18 |
Lars Jakobsson
DFI | Director of Finance/CFO | 67 | - |
Gustav Sten
COO | Chief Operating Officer | - | 31/12/18 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Chief Tech/Sci/R&D Officer | - | 31/12/14 | |
Alona Nyberg
IRC | Investor Relations Contact | - | 31/12/18 |
Gunnar Wahlberg
SAM | Sales & Marketing | 54 | 31/12/20 |
Tina Yang
PRN | Corporate Officer/Principal | - | 31/12/16 |
Peter Lowendahl
LAW | General Counsel | - | 31/12/18 |
Filip Fogdestam
PRN | Corporate Officer/Principal | - | 31/12/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 31/12/21 | |
Director/Board Member | 63 | 30/04/21 | |
Clas Runnberg
BRD | Director/Board Member | 72 | 31/12/22 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Max Pihlqvist
BRD | Director/Board Member | 37 | 31/12/21 |
Eva Nordström
BRD | Director/Board Member | 54 | 31/12/19 |
Director/Board Member | - | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 230,361,066 | 102,183,486 ( 44.36 %) | 0 | 44.36 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |